Functional dyspepsia is a common digestive disorder, with more than one in ten Koreans suffering. Some of these patients wander from one hospital to another, searching for a precise cause and ...

The FDA has approved a first-in-class antipsychotic that targets cholinergic receptors without blocking dopamine receptors.

Without proper treatment and prevention, GERD can cause damage to the esophagus ... Her clinical and research focus includes ...

The FDA on Thursday approved xanomeline and trospium chloride (Cobenfy) for schizophrenia in adults, the first new class of ...

U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...

One of the stranger legends surrounding the controversial Confederate general Stonewall Jackson is the fact that Jackson's ...

The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should ...

KarXT — now with the brand name Cobenfy— is expected to be available in October with a list price of about $22,500 annually.

Frequent burping, often due to alcohol, acid reflux, or gastrointestinal issues, can be managed by lifestyle changes and ...

Leaky gut syndrome is believed to be the result or cause of some chronic conditions. Learn how symptoms may have to do with ...

Apple cider vinegar has a reputation for improving metabolic health, but does it work? Find out here and where to buy the best apple cider ...

Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults ...